Boundless Cash from 2010 to 2024
| BOLD Stock | USD 2.69 0.14 5.49% |
Cash | First Reported 2016-09-30 | Previous Quarter 31.4 M | Current Value 40.2 M | Quarterly Volatility 63.6 M |
Check Boundless Bio, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Boundless Bio,'s main balance sheet or income statement drivers, such as Depreciation And Amortization of 909.1 K, Selling General Administrative of 11.5 M or Other Operating Expenses of 55.2 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. Boundless financial statements analysis is a perfect complement when working with Boundless Bio, Valuation or Volatility modules.
Boundless | Cash |
Latest Boundless Bio,'s Cash Growth Pattern
Below is the plot of the Cash of Boundless Bio, Common over the last few years. Cash refers to the most liquid asset of Boundless Bio, Common, which is listed under current asset account on Boundless Bio, Common balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Boundless Bio, customers. The amounts must be unrestricted with restricted cash listed in a different Boundless Bio, account. It is the total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts. Boundless Bio,'s Cash historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Boundless Bio,'s overall financial position and show how it may be relating to other accounts over time.
| Cash | 10 Years Trend |
|
Cash |
| Timeline |
Boundless Cash Regression Statistics
| Arithmetic Mean | 40,922,387 | |
| Geometric Mean | 35,642,035 | |
| Coefficient Of Variation | 72.08 | |
| Mean Deviation | 13,790,215 | |
| Median | 36,359,000 | |
| Standard Deviation | 29,494,920 | |
| Sample Variance | 870T | |
| Range | 133.4M | |
| R-Value | (0.05) | |
| Mean Square Error | 934.2T | |
| R-Squared | 0 | |
| Significance | 0.85 | |
| Slope | (352,612) | |
| Total Sum of Squares | 12179.3T |
Boundless Cash History
Other Fundumenentals of Boundless Bio, Common
Boundless Bio, Cash component correlations
Click cells to compare fundamentals
About Boundless Bio, Financial Statements
Boundless Bio, stakeholders use historical fundamental indicators, such as Boundless Bio,'s Cash, to determine how well the company is positioned to perform in the future. Although Boundless Bio, investors may analyze each financial statement separately, they are all interrelated. For example, changes in Boundless Bio,'s assets and liabilities are reflected in the revenues and expenses on Boundless Bio,'s income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Boundless Bio, Common. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Cash | 23.7 M | 38.5 M | |
| Cash And Short Term Investments | 120.8 M | 121.8 M | |
| Change In Cash | 12.8 M | 15.5 M | |
| Free Cash Flow | -47.5 M | -49.9 M | |
| Begin Period Cash Flow | 11.5 M | 10.9 M | |
| Other Cashflows From Financing Activities | 97.9 M | 101.2 M | |
| Other Non Cash Items | 2.4 M | 2.5 M | |
| Total Cash From Operating Activities | -46.9 M | -49.2 M | |
| Total Cash From Financing Activities | 97.9 M | 106.4 M | |
| End Period Cash Flow | 24.3 M | 38.7 M | |
| Free Cash Flow Yield | -213.5 K | -202.9 K | |
| Operating Cash Flow Per Share | (2.11) | (2.21) | |
| Free Cash Flow Per Share | (2.14) | (2.24) | |
| Cash Per Share | 5.43 | 3.54 | |
| Capex To Operating Cash Flow | (0.01) | (0.01) | |
| EV To Operating Cash Flow | 0.46 | 0.48 | |
| EV To Free Cash Flow | 0.45 | 0.48 | |
| Cash Ratio | 2.53 | 4.39 | |
| Cash Conversion Cycle | (847.47) | (889.84) | |
| Free Cash Flow Operating Cash Flow Ratio | 1.01 | 1.22 | |
| Cash Flow Coverage Ratios | (13.76) | (14.44) | |
| Cash Flow To Debt Ratio | (13.76) | (14.44) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| NVDA | NVIDIA | |
| CRESY | Cresud SACIF y | |
| GOOG | Alphabet Inc Class C |
Check out the analysis of Boundless Bio, Correlation against competitors. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Boundless Bio,. If investors know Boundless will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Boundless Bio, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Boundless Bio, Common is measured differently than its book value, which is the value of Boundless that is recorded on the company's balance sheet. Investors also form their own opinion of Boundless Bio,'s value that differs from its market value or its book value, called intrinsic value, which is Boundless Bio,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Boundless Bio,'s market value can be influenced by many factors that don't directly affect Boundless Bio,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Boundless Bio,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Boundless Bio, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Boundless Bio,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.